Pricing challenge in US biz, rich valuations may weigh on pharma stocks

The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......

6 major companies found manufacturing 'substandard' drugs

  Six pharma majors were sent seven alerts last financial year At least six major pharmaceutical companies, including Cipla, Ipca Labs, Alkem Labs, Morepen Labs, Abbott and Sanofi were found......

AIDS, TB next big revenue source for pharma majors

The Indian pharmaceutical companies are faced with a $2 billion opportunity each year, with the AIDS epidemic and resurgence in tuberculosis and malaria sweeping the world. While the early movers......

Sensex down 25 points at 11,699

The markets closed marginally in the red on the Future & Options settlement day. The Sensex closed at 11,699.05 down 24.87 points. The Nifty down 16 points to close at 3414. The BSE Small Cap Index......